Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles

PURPOSE: Enhanced drug exposure to the ocular surface typically relies on inclusion of viscosity-enabling agents, whereas delivery to the back of the eye generally focuses on invasive means, such as intraocular injections. Using our novel mucus-penetrating particle (MPP) technology, which rapidly an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Vis Sci Technol
Autors principals: Schopf, Lisa R., Popov, Alexey M., Enlow, Elizabeth M., Bourassa, James L., Ong, Winston Z., Nowak, Pawel, Chen, Hongming
Format: Artigo
Idioma:Inglês
Publicat: The Association for Research in Vision and Ophthalmology 2015
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4473722/
https://ncbi.nlm.nih.gov/pubmed/26101724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/tvst.4.3.11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars